HK1060055A1 - Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine - Google Patents

Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine

Info

Publication number
HK1060055A1
HK1060055A1 HK04102989.5A HK04102989A HK1060055A1 HK 1060055 A1 HK1060055 A1 HK 1060055A1 HK 04102989 A HK04102989 A HK 04102989A HK 1060055 A1 HK1060055 A1 HK 1060055A1
Authority
HK
Hong Kong
Prior art keywords
mucoadhesive
veterinary
active
pharmaceutical preparation
human medicine
Prior art date
Application number
HK04102989.5A
Other languages
English (en)
Inventor
Tina Rademacher
Frank Seiberts
Petra Brandt
Markus Krumme
Falkenhausen Christian Von
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of HK1060055A1 publication Critical patent/HK1060055A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK04102989.5A 2001-02-19 2004-04-28 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine HK1060055A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10107659A DE10107659B4 (de) 2001-02-19 2001-02-19 Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
PCT/EP2002/001314 WO2002066016A2 (de) 2001-02-19 2002-02-08 Mucoadhäsive zerfallsfähige arzneizubereitung

Publications (1)

Publication Number Publication Date
HK1060055A1 true HK1060055A1 (en) 2004-07-30

Family

ID=7674531

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04102989.5A HK1060055A1 (en) 2001-02-19 2004-04-28 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine

Country Status (18)

Country Link
US (1) US8906406B2 (xx)
EP (1) EP1368004B1 (xx)
JP (2) JP2004529101A (xx)
KR (1) KR20030076687A (xx)
CN (1) CN1599599A (xx)
AR (1) AR033418A1 (xx)
AT (1) ATE429213T1 (xx)
AU (1) AU2002250904B2 (xx)
BR (1) BR0207614A (xx)
CA (1) CA2438651C (xx)
DE (2) DE10107659B4 (xx)
DK (1) DK1368004T3 (xx)
ES (1) ES2328115T3 (xx)
HK (1) HK1060055A1 (xx)
MX (1) MXPA03007434A (xx)
PT (1) PT1368004E (xx)
WO (1) WO2002066016A2 (xx)
ZA (1) ZA200306563B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US6887493B2 (en) * 2000-10-25 2005-05-03 Adi Shefer Multi component controlled release system for oral care, food products, nutraceutical, and beverages
DE10224612A1 (de) * 2002-06-04 2003-12-24 Lohmann Therapie Syst Lts Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
DE10251963A1 (de) * 2002-11-08 2004-05-19 Lts Lohmann Therapie-Systeme Ag Transmucosale pharmazeutische Darreichungsform
DE10256774A1 (de) * 2002-12-05 2004-06-24 Lts Lohmann Therapie-Systeme Ag Transmucosale und transdermale Arzneimittel mit verbesserter Wirkstoffresorption
US20040202698A1 (en) * 2003-04-02 2004-10-14 The Procter & Gamble Company Drug delivery systems comprising an encapsulated active ingredient
DE102004017030A1 (de) * 2004-04-02 2005-10-20 Schering Ag Flachkapseln
FI20041425A0 (fi) 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
EP1835886A1 (en) * 2004-12-23 2007-09-26 Warner-Lambert Company LLC Orally disintegrating pharmaceutical compositions with sensory cue agents
JP5507840B2 (ja) * 2005-09-19 2014-05-28 ユニバーシティ・オブ・ザ・ウィットウォータースランド・ヨハネスブルグ 口腔粘膜医薬投与形態
US8097245B2 (en) * 2005-12-28 2012-01-17 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
CA2639921C (en) * 2006-01-23 2014-01-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Microspheres comprising nanocapsules containing a lipophilic drug
DE102006027794A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antihypertonie-Kombinationswafer
DE102006027795A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Raucherentwöhnungs-Kombinationswafer
EP2117354B1 (en) 2006-12-18 2018-08-08 Advanced BioNutrition Corp. A dry food product containing live probiotic
FR2935084B1 (fr) * 2008-08-19 2011-05-06 Pancosma Sa Pour L Ind Des Produits Biochimiques Additif pour l'alimentation animale et son procede de preparation
CA2756883C (en) 2009-03-27 2018-01-09 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
ES2643148T3 (es) 2009-05-26 2017-11-21 Advanced Bionutrition Corporation Composición en polvo seco estable que comprende microorganismos biológicamente activos y/o materiales bioactivos y métodos de producción
NZ601017A (en) 2010-01-28 2014-07-25 Advanced Bionutrition Corp Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
SI2603100T1 (en) 2010-08-13 2018-08-31 Advanced Bionutrition Corp. DRY COMPOSITION FOR STABILIZING BETWEEN STORAGE FOR BIOLOGICAL MATERIALS
FR2972327B1 (fr) * 2011-03-11 2017-08-11 Laboratoires Le Stum Composition nutraceutique mucoadhesive comprenant une association d'antioxydants
DE102014116903A1 (de) * 2014-08-18 2016-02-18 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Cineolhaltige Zusammensetzung für die nasale Applikation
DE102014119576A1 (de) 2014-12-23 2016-06-23 Ernst-Moritz-Arndt-Universität Greifswald Pharmazeutische Arzneimittelform zur Applikation auf Schleimhäuten
EP3328215B1 (en) 2015-07-29 2021-07-07 Advanced BioNutrition Corp. Stable dry probiotic compositions for special dietary uses
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
US20210161726A1 (en) 2017-11-06 2021-06-03 Besthealth4U Unipessoal Lda Adhesion Materials and Methods of Manufacture
WO2021056109A1 (en) * 2019-09-24 2021-04-01 Medisca Pharmaceutique Inc. Gel base composition for compounding into a mucoadhesive delivery system
DE102021130950A1 (de) * 2021-11-25 2023-05-25 Lts Lohmann Therapie-Systeme Ag. Applikationshilfe
CN116459268B (zh) * 2023-03-29 2024-09-20 淄博维希尔生物技术有限公司 一种含替米考星的溶液组合物及其制备方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3972995A (en) * 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4175326A (en) * 1977-10-26 1979-11-27 Forsyth Dental Infirmary For Children Hollow-fiber devices for and a method of the treament and diagnosis of oral diseases
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4329333A (en) 1980-11-24 1982-05-11 Arthur Barr Method for the oral treatment of dogs and other animals
US4597959A (en) * 1982-04-30 1986-07-01 Arthur Barr Sustained release breath freshener, mouth and palate coolant wafer composition and method of use
US5225196A (en) * 1983-11-14 1993-07-06 Columbia Laboratories, Inc. Bioadhesive compositions and methods of treatment therewith
EP0205336B1 (en) * 1985-06-11 1991-09-11 Teijin Limited Oral sustained release pharmaceutical preparation
JP2702953B2 (ja) * 1988-01-30 1998-01-26 オリンパス光学工業株式会社 薬液含浸セラミックス
US4948580A (en) * 1988-12-08 1990-08-14 E. R. Squibb & Sons, Inc. Muco-bioadhesive composition
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5750136A (en) * 1989-11-03 1998-05-12 Riker Laboratories, Inc. Bioadhesive composition and patch
US5558880A (en) * 1989-12-22 1996-09-24 Janssen Pharmaceutica Inc. Pharmaceutical and other dosage forms
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
KR100225153B1 (ko) * 1991-04-08 1999-10-15 다께우찌 마사야쓰 단백성 생리학적 활성 물질을 함유하는 다공성 고형 제제
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
US5643582A (en) * 1992-03-30 1997-07-01 Smithkline Beecham Corporation Moisturizer
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US6066337A (en) * 1994-01-27 2000-05-23 The Board Of Regents Of The University Of Oklahoma And Janssen Pharmaceutica, Inc. Method for producing a rapidly dissolving dosage form
US5516522A (en) * 1994-03-14 1996-05-14 Board Of Supervisors Of Louisiana State University Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same
DE4419824A1 (de) 1994-06-07 1995-12-14 Lohmann Therapie Syst Lts Volumen-expandierbares, als Wirkstoffträger insbesondere zur oralen Anwendung geeignete flächige Anwendungsform
US5639469A (en) * 1994-06-15 1997-06-17 Minnesota Mining And Manufacturing Company Transmucosal delivery system
US5660848A (en) 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US5942243A (en) * 1996-11-12 1999-08-24 Polytherapeutics, Inc. Mucoadhesive compositions for administration of biologically active agents to animal tissue
DE19652257A1 (de) * 1996-12-16 1998-06-18 Lohmann Therapie Syst Lts Einzeln dosierte, bei Kontakt mit Flüssigkeit schnell zerfallende, wirkstoff- und insbesondere aromastoffhaltige, folienförmige Darreichnungsform
IT1289160B1 (it) * 1997-01-08 1998-09-29 Jagotec Ag Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
FR2766708B1 (fr) * 1997-07-30 2000-05-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
PT1021241E (pt) 1997-10-06 2002-01-30 Adalbert Raps Stiftung Processo para a producao de um produto sob a forma de po a partir de uma substancia ou mistura de substancias liquida
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
JP2002526403A (ja) * 1998-10-02 2002-08-20 スリーエム イノベイティブ プロパティズ カンパニー 粘膜を起点としたデリバリーシステムおよび動物への適用
WO2000035418A2 (en) * 1998-12-18 2000-06-22 Bayer Corporation Chewable drug delivery system
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6180682B1 (en) * 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception
US6231957B1 (en) * 1999-05-06 2001-05-15 Horst G. Zerbe Rapidly disintegrating flavor wafer for flavor enrichment
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
DE19954245A1 (de) * 1999-11-11 2001-07-19 Lohmann Therapie Syst Lts Mehrschichtige filmförmige Zubereitung aus hydrophilen Polymeren zur schnellen Freisetzung von Wirkstoffen
AU2023401A (en) 1999-12-01 2001-06-12 Natco Pharma Limited A rapid acting freeze dired oral pharmaceutical composition for treating migraine
EP1120109A3 (en) * 2000-01-24 2002-07-10 Pfizer Products Inc. Rapidly disintegrating and fast dissolving solid dosage form
KR100393478B1 (ko) * 2000-03-29 2003-08-06 주식회사종근당 자가유화 매트릭스형 경점막·경피흡수제제
DE10032456A1 (de) 2000-07-04 2002-01-31 Lohmann Therapie Syst Lts Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen

Also Published As

Publication number Publication date
US8906406B2 (en) 2014-12-09
DK1368004T3 (da) 2009-08-17
ZA200306563B (en) 2004-02-10
CN1599599A (zh) 2005-03-23
PT1368004E (pt) 2009-07-27
JP2004529101A (ja) 2004-09-24
AR033418A1 (es) 2003-12-17
WO2002066016A2 (de) 2002-08-29
DE10107659A1 (de) 2002-09-05
CA2438651A1 (en) 2002-08-29
MXPA03007434A (es) 2003-11-18
EP1368004A2 (de) 2003-12-10
WO2002066016A3 (de) 2003-10-02
JP2009185078A (ja) 2009-08-20
BR0207614A (pt) 2004-01-13
CA2438651C (en) 2010-03-30
AU2002250904B2 (en) 2006-05-04
DE10107659B4 (de) 2008-03-13
ATE429213T1 (de) 2009-05-15
EP1368004B1 (de) 2009-04-22
ES2328115T3 (es) 2009-11-10
US20040081699A1 (en) 2004-04-29
DE50213479D1 (de) 2009-06-04
KR20030076687A (ko) 2003-09-26

Similar Documents

Publication Publication Date Title
HK1060055A1 (en) Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine
AU2002250904A1 (en) Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine
AU2002347575A1 (en) Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same
HUP0302550A3 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines and pharmaceutical compositions containing them
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
HUP0402661A3 (en) Formulation and dosage form for the controlled delivery of therapeutic agents
HUP0400918A3 (en) Utilization of pyrazoline derivatives in the preparation of pharmaceutical compositions for the prevention and/or treatment of proliferative cell diseases
EP1367060A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE
EP1364957A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE
IL162293A0 (en) Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
EP1435982A4 (en) SYSTEM FOR ADMINISTERING PHARMACEUTICAL, NUTRITIONAL AND COSMETIC INGREDIENTS
IL151314A0 (en) Micelles, methods for their preparation and methods for delivery of micelles to patients
IL149495A0 (en) Pharmaceutical formulations comprising p2t receptor antagonist and anti-thrombotic agent and use thereof in therapy
EP1257255A4 (en) THERAPEUTIC PRODUCT, ITS USE AND MANUFACTURE
HUP0301460A3 (en) Use of antiprogestins for producing pharmaceutical compositions for prohylaxis and treatment of hormone-dependent diseases
HRP20020372A2 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
HUP0401369A3 (en) Pharmaceutical formulation comprising (r)-bicalutamide, process for its preparation and use thereof
HUP0303597A3 (en) Diposable vaginal cannula for the simultaneous administration of drugs in different forms
NO20026055L (no) Farmasöytiske komponenter innbefattende humant paratyreoideahormon og farmasöytiske sammenstninger for nasal administrering inneholdendekomponentene
EP1583545A4 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF PEPTIDES OF HIV GP41 AND ITS THERAPEUTIC USE
IL160886A0 (en) Nicotine containing pharmaceutical formulations and use thereof
PL365029A1 (en) Novel vaccine for prophylaxis and therapy in veterinary and human medicine
GB0113725D0 (en) Nasal delivery of pharmaceutical compositions including vaccines and biotechnological products
AU2002331357A1 (en) Vaccine for prophylaxis and therapy of dermatophytosis in veterinary and human medicine
EP1352652A4 (en) FAT COMPOSITION FOR ORAL OR ENTERAL ADMINISTRATION AND HEXACOSIC ACID INHIBITORS

Legal Events

Date Code Title Description
CORR Corrigendum

Free format text: CORRECTED DATA OF SECTION 20 TO JOURNAL OF 20040730: [30] 19.02.2001 DE 10107659.2

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130208